{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:13:20Z","timestamp":1789456400783,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00417-026-07256-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:21:14Z","timestamp":1777008074000},"page":"2795-2803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Subconjunctival injectable platelet-rich fibrin for severe dry eye disease: Preliminary clinical results"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-6240","authenticated-orcid":false,"given":"Huri","family":"Sabur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-331X","authenticated-orcid":false,"given":"Ayse Nur","family":"Coban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6352-9786","authenticated-orcid":false,"given":"Nese","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-5551","authenticated-orcid":false,"given":"Alperen","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"7256_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2025.09.035","volume":"282","author":"VL Perez","year":"2025","unstructured":"Perez VL, Chen W, Craig JP, Dogru M, Jones L, Stapleton F, Wolffsohn JS, Sullivan DA (2025) TFOS DEWS III: executive summary. Am J Ophthalmol 282:135\u2013145. https:\/\/doi.org\/10.1016\/j.ajo.2025.09.035","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"7256_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3341\/kjo.2016.30.2.101","volume":"30","author":"JH Lee","year":"2016","unstructured":"Lee JH, Kim MJ, Ha SW, Kim HK (2016) Autologous platelet-rich plasma eye drops in the treatment of recurrent corneal erosions. Korean J Ophthalmol 30(2):101\u2013107. https:\/\/doi.org\/10.3341\/kjo.2016.30.2.101","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"7256_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/tjo.galenos.2025.47717","volume":"55","author":"S Sachan","year":"2025","unstructured":"Sachan S, Dwivedi K, Singh SP, Kumar S, Singh VK (2025) Comparison of 20% autologous platelet-rich plasma versus conventional treatment in moderate to severe dry eye patients. Turk J Ophthalmol 55(3):112\u2013119. https:\/\/doi.org\/10.4274\/tjo.galenos.2025.47717","journal-title":"Turk J Ophthalmol"},{"issue":"4","key":"7256_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/ICU.0000000000000169","volume":"26","author":"JL Alio","year":"2015","unstructured":"Alio JL, Rodriguez AE, Wr\u00f3belDudzi\u0144ska D (2015) Eye platelet-rich plasma in the treatment of ocular surface disorders. Curr Opin Ophthalmol 26(4):325\u201332. https:\/\/doi.org\/10.1097\/ICU.0000000000000169","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"7256_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.fsc.2019.03.005","volume":"27","author":"K Karimi","year":"2019","unstructured":"Karimi K, Rockwell H (2019) The benefits of platelet-rich fibrin. Facial Plast Surg Clin North Am 27(3):331\u2013340. https:\/\/doi.org\/10.1016\/j.fsc.2019.03.005","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"5","key":"7256_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jocd.13742","volume":"20","author":"B Shashank","year":"2021","unstructured":"Shashank B, Bhushan M (2021) Injectable platelet-rich fibrin (PRF): the newest biomaterial and its use in various dermatological conditions in our practice\u2014a case series. J Cosmet Dermatol 20(5):1421\u20131426. https:\/\/doi.org\/10.1111\/jocd.13742","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"7256_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00068-017-0767-9","volume":"44","author":"J Choukroun","year":"2018","unstructured":"Choukroun J, Ghanaati S (2018) Reduction of relative centrifugation force within injectable platelet-rich fibrin (PRF) concentrates advances patients\u2019 own inflammatory cells, platelets and growth factors: the first introduction to the low-speed centrifugation concept. Eur J Trauma Emerg Surg 44(1):87\u201395. https:\/\/doi.org\/10.1007\/s00068-017-0767-9","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"2","key":"7256_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.33204\/mucosa.707865","volume":"3","author":"ZB \u00d6zsa\u011f\u0131r","year":"2020","unstructured":"\u00d6zsa\u011f\u0131r ZB, Tunal\u0131 M (2020) Injectable platelet-rich fibrin: a new material in medicine and dentistry. Mucosa 3(2):27\u201333. https:\/\/doi.org\/10.33204\/mucosa.707865","journal-title":"Mucosa"},{"issue":"5","key":"7256_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55050141","volume":"55","author":"AF Grecu","year":"2019","unstructured":"Grecu AF, Reclaru L, Ardelean LC, Nica O, Ciuc\u0103 EM, Ciurea ME (2019) Platelet-rich fibrin and its emerging therapeutic benefits for musculoskeletal injury treatment. Medicina (Kaunas) 55(5):141. https:\/\/doi.org\/10.3390\/medicina55050141","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"7256_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10792-024-02920-5","volume":"44","author":"A Bahar","year":"2024","unstructured":"Bahar A, Sabur H (2024) Effects of injectable platelet-rich fibrin (i-PRF) on pterygium surgery with conjunctival autograft. Int Ophthalmol 44(1):65. https:\/\/doi.org\/10.1007\/s10792-024-02920-5","journal-title":"Int Ophthalmol"},{"issue":"5","key":"7256_CR11","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.2024-0326","volume":"88","author":"A Bahar","year":"2025","unstructured":"Bahar A, Sabur H, Acar M (2025) Injectable platelet-rich fibrin for corneal epithelium healing: an in vivo confocal microscopy study after crosslinking. Arq Bras Oftalmol 88(5):e20240326. https:\/\/doi.org\/10.5935\/0004-2749.2024-0326","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"7256_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, Sullivan BD, Tomlinson A, Tong L, Villani E, Yoon KC, Jones L, Craig JP (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15(3):539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2","journal-title":"Ocul Surf"},{"issue":"2","key":"7256_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/09273948.2022.2027461","volume":"30","author":"KJ Hirabayashi","year":"2022","unstructured":"Hirabayashi KJ, Akpek EK, Ahmad S (2022) Outcome measures to assess dry eye severity: a review. Ocul Immunol Inflamm 30(2):282\u2013289. https:\/\/doi.org\/10.1080\/09273948.2022.2027461","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"7256_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","volume":"98","author":"C Baudouin","year":"2014","unstructured":"Baudouin C, Aragona P, Van Setten G, Rolando M, Irke\u00e7 M, Ben\u00edtez del Castillo J, Geerling G, Labetoulle M, Bonini S, ODISSEY European Consensus Group members (2014) Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol 98(9):1168\u201376. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304619","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"7256_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/17460751.2025.2544486","volume":"20","author":"AM Mora","year":"2025","unstructured":"Mora AM, C\u00f3rdoba CM, Jimenez-Mora MA, Padilla-Pantoja FD (2025) Sustained long-term benefits of autologous subconjunctival platelet-rich plasma injections for severe dry eye disease. Regen Med 20(8):331\u2013338. https:\/\/doi.org\/10.1080\/17460751.2025.2544486","journal-title":"Regen Med"},{"issue":"6","key":"7256_CR16","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1364\/BOE.10.002744","volume":"10","author":"H Stegmann","year":"2019","unstructured":"Stegmann H, Aranha Dos Santos V, Messner A, Unterhuber A, Schmidl D, Garh\u00f6fer G, Schmetterer L, Werkmeister RM (2019) Automatic assessment of tear film and tear meniscus parameters in healthy subjects using ultrahigh-resolution optical coherence tomography. Biomed Opt Express 10(6):2744\u20132756. https:\/\/doi.org\/10.1364\/BOE.10.002744","journal-title":"Biomed Opt Express"},{"issue":"Suppl 11","key":"7256_CR17","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/ICO.0000000000000583","volume":"34","author":"R Akiyama","year":"2015","unstructured":"Akiyama R, Usui T, Yamagami S (2015) Diagnosis of dry eye by tear meniscus measurements using anterior segment swept-source optical coherence tomography. Cornea 34(Suppl 11):S115\u2013S120. https:\/\/doi.org\/10.1097\/ICO.0000000000000583","journal-title":"Cornea"},{"key":"7256_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","volume":"279","author":"L Jones","year":"2025","unstructured":"Jones L, Craig JP, Markoulli M, Karpecki P, Akpek EK, Basu S, Bitton E, Chen W, Dhaliwal DK, Dogru M, Gomes JAP, Koehler M, Mehta JS, Perez VL, Stapleton F, Sullivan DA, Tauber J, Tong L, Trav\u00e9-Huarte S, Wolffsohn JS, TFOS Collaborator Group (2025) TFOS DEWS III: management and therapy. Am J Ophthalmol 279:289\u2013386. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.039","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"7256_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tripleo.2009.04.020","volume":"108","author":"DM Dohan Ehrenfest","year":"2009","unstructured":"Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB (2009) In vitro effects of Choukroun\u2019s platelet-rich fibrin (PRF) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108(3):341\u2013352. https:\/\/doi.org\/10.1016\/j.tripleo.2009.04.020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"7256_CR20","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.2147\/OPTH.S265701","volume":"14","author":"J You","year":"2020","unstructured":"You J, Hodge C, Hoque M, Petsoglou C, Sutton G (2020) Human platelets and derived products in treating ocular surface diseases: a systematic review. Clin Ophthalmol 14:3195\u20133210. https:\/\/doi.org\/10.2147\/OPTH.S265701","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"7256_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000100933","volume":"39","author":"JL Alio","year":"2007","unstructured":"Alio JL, Colecha JR, Pastor S, Rodriguez A, Artola A (2007) Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res 39(3):124\u2013129. https:\/\/doi.org\/10.1159\/000100933","journal-title":"Ophthalmic Res"},{"issue":"12","key":"7256_CR22","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/bmt.2012.64","volume":"47","author":"S Pezzotta","year":"2012","unstructured":"Pezzotta S, Del Fante C, Scudeller L, Cervio M, Antoniazzi ER, Perotti C (2012) Autologous platelet lysate for treatment of refractory ocular graft-versus-host disease. Bone Marrow Transplant 47(12):1558\u20131563. https:\/\/doi.org\/10.1038\/bmt.2012.64","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"7256_CR23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ophtha.2006.10.044","volume":"114","author":"JL Alio","year":"2007","unstructured":"Alio JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J (2007) Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology 114(7):1286-1293.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2006.10.044","journal-title":"Ophthalmology"},{"issue":"1","key":"7256_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/ICO.0000000000000016","volume":"33","author":"MY Avila","year":"2014","unstructured":"Avila MY (2014) Restoration of human lacrimal function following platelet-rich plasma injection. Cornea 33(1):18\u201321. https:\/\/doi.org\/10.1097\/ICO.0000000000000016","journal-title":"Cornea"},{"issue":"1","key":"7256_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51794","volume":"16","author":"A Hassan","year":"2024","unstructured":"Hassan A, Telandro A, Barguigua A, Baba M, K\u00f6rber N (2024) Evaluation of the use of highly concentrated autologous platelet-rich plasma and platelet-rich fibrin membrane to improve the outcome in the management of severe dry eye disease, corneal neurotrophic ulcer and corneal burn. Cureus 16(1):e51794. https:\/\/doi.org\/10.7759\/cureus.51794","journal-title":"Cureus"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07256-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07256-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07256-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:42Z","timestamp":1789455222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07256-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7256"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07256-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was obtained from the Ethics Committee of Ankara Etlik City Hospital, T\u00fcrkiye (Approval No: AESH-EK1-2023-653). All procedures performed in this study were conducted in accordance with the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no financial interests.","order":3,"name":"Ethics","label":"Financial interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}